Peer Exchange
February 15, 2019 –
Define unmanaged/uncontrolled severe asthma and provide an overview of the available biologics.
February 15, 2019 –
A review of Omalizumab’s adverse effects, mechanism, and ideal patient factors.
February 12, 2019 –
Important touchpoints for patient management of CDK4/6 inhibitors.
February 12, 2019 –
Outlining different dispensing options for CDK4/6 inhibitors including in-clinic, specialty, and medically integrated dispensing.
February 08, 2019 –
A discussion on the biomarkers used to determine efficacy with specific biologics.
February 08, 2019 –
Experts debate the challenges with biologics in the treatment plan for severe asthma.
February 05, 2019 –
Roles of the members of the cross-functional team managing patients taking CDK4/6 inhibitors.
February 05, 2019 –
Feedback from patients with metastatic breast cancer including their increase in quality of life when taking an oral CDK4/6 inhibitor and the value of continuous dosing of abemaciclib.
February 05, 2019 –
A brief review of emerging therapies in the pipeline for HIV treatment.
February 05, 2019 –
William Short, MD, MPH, AAHIVS, reacts to current barriers in managing patients with HIV, including navigating through formulary restrictions and reinforcing education on preventive strategies and treatment options to patients and healthcare providers.
